Study S001754

Clinical and Histopathological Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01687582
Study type: INTERVENTIONAL
Masking: NONE
Status: COMPLETED
Enrollment: 10
Start: 2012-01
Primary completion: 2012-12
Lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions: Type 2 Diabetes; Psoriasis
Interventions: DRUG:GLP-1 analog
Results posted: FALSE

Registered primary outcomes

Improvement of PASI score [4 to 6 months]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0019565	Improvement of psoriasis during exenatide treatment in a patient with diabetes. Buysschaert M, Diabetes & metabolism	2012	Case report	PMID 22227407 DOI	registry reference BACKGROUND:22227407
R0021902	Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Hogan AE, Diabetologia	2011	Preclinical	PMID 21744074 DOI	registry reference BACKGROUND:21744074